Evidence map›Paper›PMID 36570629›Full record

ArticleIPEM-translation

Safe and effective re-use policy for high-efficiency filtering facepiece respirators (FFRS): Experience of one hospital during the Covid-19 pandemic in 2020.

Sergio I Prada, Álvaro Vivas, Maria Paula Garcia-Garcia, Erik Rosero, Marly Orrego, Juan Sebastián Candelo, John España, Germán Soto, Diego Martínez, Leonardo García

Open access · goldAbstract read
In one paragraph

Article in IPEM-translation. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Sergio I PradaFundación Valle del Lili. Centro de Investigaciones Clínicas. Cra. 98 # 18-49, 760031, Cali, Colombia.
Álvaro VivasFundación Valle del Lili. Centro de Investigaciones Clínicas. Cra. 98 # 18-49, 760031, Cali, Colombia.
Maria Paula Garcia-GarciaFundación Valle del Lili. Centro de Investigaciones Clínicas. Cra. 98 # 18-49, 760031, Cali, Colombia.
Erik RoseroFundación Valle del Lili. Centro de Investigaciones Clínicas. Cra. 98 # 18-49, 760031, Cali, Colombia.
Marly OrregoFundación Valle del Lili. Centro de Investigaciones Clínicas. Cra. 98 # 18-49, 760031, Cali, Colombia.
Juan Sebastián CandeloFundación Valle del Lili. Centro de Investigaciones Clínicas. Cra. 98 # 18-49, 760031, Cali, Colombia.
John EspañaFundación Valle del Lili. Centro de Investigaciones Clínicas. Cra. 98 # 18-49, 760031, Cali, Colombia.
Germán SotoFundación Valle del Lili. Centro de Investigaciones Clínicas. Cra. 98 # 18-49, 760031, Cali, Colombia.
Diego MartínezFundación Valle del Lili. Centro de Investigaciones Clínicas. Cra. 98 # 18-49, 760031, Cali, Colombia.
Leonardo GarcíaFundación Valle del Lili. Centro de Investigaciones Clínicas. Cra. 98 # 18-49, 760031, Cali, Colombia.
Fundación Valle del Lili · CO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The high transmissibility rate of the Severe Acute Respiratory Syndrome Coronavirus 2 facilitated an exponential growth in the number of infections, posing a tremendous threat to healthcare systems across the world. The use of Non-oil 95% efficiency (N95) respirators demonstrated to reduce the risk of virus transmission. The escalated demand in N95 respirators during 2020 generated a massive shortage worldwide which resulted in serious implications, one being an increase in healthcare providers' costs. In response, various optimization strategies were implemented. This study aimed to assess the implementation of a safe and effective re-use policy for high-efficiency filtering facepiece respirators (FFRs) in a high-complexity university hospital in 2020. Associated costs were estimated through a descriptive accounting analysis of resources saved. Acceptability, appropriateness, and feasibility rates were 80.5%, 78.8%, and 83.6%, respectively. With an implementation cost of approximately 10,000 USD, there was a 56.1% reduction in FFRs consumption, compared with a non-policy scenario, with savings exceeding 500,000 USD in 2020. In a pandemic scenario where it is vital to spare resources, a FFRs rational use policy demonstrated to be a highly cost-efficient alternative in order to save resources without increasing contagion risk among healthcare workers.

Indexed as

ColombiaCosts savingsCOVID-19High-efficiency filtering facepiece respiratorsHospitals costsN95 RespiratorsSARS-CoV-2

Identifiers

PMID36570629
PMCPMC9769100
OpenAlexW4312105355

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.